Jump to content

valueventures

Member
  • Posts

    271
  • Joined

  • Last visited

  • Days Won

    3

valueventures last won the day on April 21

valueventures had the most liked content!

1 Follower

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

valueventures's Achievements

Collaborator

Collaborator (7/14)

  • First Post
  • Collaborator
  • Dedicated
  • Conversation Starter
  • Week One Done

Recent Badges

3

Reputation

  1. Mine are probably IWG, MATR, and GRUSF.
  2. Curious what stocks intrigue you. My most actionable watchlist ideas at the moment are APO, IBKR, BRO, and MUSA, but all are too expensive at the moment.
  3. In addition to the 2025 Portfolio thread, figured I’d start a thread focused on sharing everyone’s top ideas. What stock or handful of stocks do you expect to outperform and why? Looking forward to hearing responses, thanks!
  4. While all the names referenced in this thread have been quality compounders, they obviously have large market caps. Curious if anyone has thoughts on companies that are more small-to-mid cap in size that are earlier in their compounding lifecycles. I own FFH over BRK because it is much smaller and should therefore compound from a lower base, and am looking for a similar dynamic among insurance brokers. Thanks!
  5. What's your thesis on SCR.TO? I'm long as well, but this one doesn't get much discussion here. Thanks!
  6. Also a small starter in SNDL...hoping for a quick flip on this one.
  7. Nice portfolio, but where is GLASF?!
  8. Added to GLASF on the dip
  9. I don't have a strong preference. I've read that KKR is better suited for low rate environments and APO for high rate environments, so would expect KKR to perform a bit better if/when rates get cut. Also, I follow a few hedge funds (1 Main, Greenhaven, etc.) that are long KKR. Lastly, I thought that S&P 500 index inclusion would be a catalyst for KKR (which ended up materializing and resulting in a nice pop in share price). I'd love to own APO at the right price...we'll see if the market affords me that opportunity.
  10. Why did you sell APO and KKR? Both solid long-term compounders. I only own KKR and still think it’s reasonably priced (25 P/E) despite YTD outperformance.
  11. Any current ideas for companies that you could see being acquired?
×
×
  • Create New...